| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.54B | -7.2% |
| Cost of Revenue | $7.59B | -4.2% |
| Gross Profit | $1.95B | -17.1% |
| R&D Expense | $125.0M | -3.8% |
| SG&A Expense | $899.0M | -12.7% |
| Operating Income | -$786.0M | -12.8% |
| Interest Expense | $701.0M | +3.7% |
| Pre-tax Income | -$1.22B | -22.5% |
| Income Tax | -$90.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $922.0M | -17.8% |
| Inventory | $2.22B | -2.8% |
| Current Assets | $5.69B | +10.7% |
| Total Assets | $21.70B | -5.1% |
| Current Liabilities | $3.68B | -4.4% |
| Long-term Debt | $12.61B | +0.7% |
| Stockholders' Equity | $4.05B | -21.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.15B | +18.6% |
| Capital Expenditures | $343.0M | -21.1% |
| Investing Cash Flow | -$349.0M | +25.7% |
| Financing Cash Flow | -$513.0M | +60.9% |
| Free Cash Flow | $803.0M | +51.2% |
| -117.6% |
| Net Income | -$1.17B | +23.5% |
| EPS (Basic) | -$10.64 | +23.6% |
| EPS (Diluted) | -$10.64 | +23.6% |